Intract Pharma is a biotechnology company innovating in the field of oral delivery of complex proteins such as monoclonal antibodies with a special focus on treatment of gastrointestinal and systemic immune-mediated inflammatory diseases. Intract is applying it’s Phloral™ and Soteria™ technology platform for precision delivery of proteins to the colon for local tissue and systemic immunomodulation. Our vision is to transform care for millions of patients suffering from chronic diseases by converting their potent injectable biologic medicines into safe, effective and convenient take-at-home pills.
View Top Employees from Intract PharmaWebsite | http://www.intractpharma.com |
Revenue | $5.9 million |
Employees | 10 (7 on RocketReach) |
Founded | 2016 |
Address | 2 Royal College Street, London, England NW1 0NH, GB |
Phone | +44 20 7753 5908 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Life Science, Manufacturing, Biotechnology, Science and Engineering, Pharmaceutical, Health Care |
Web Rank | 27 Million |
Keywords | Intract Pharma, Vipul Yadav London Linkedin, Vipul Yadav Intract Pharma |
Competitors | Medsyndesign Ltd, Nemaura Pharma Limited, Weston Medical Group plc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Intract Pharma employee's phone or email?
The Intract Pharma annual revenue was $5.9 million in 2024.
Vipul Yadav is the CEO of Intract Pharma.
7 people are employed at Intract Pharma.
Intract Pharma is based in London, England.
The NAICS codes for Intract Pharma are [32, 3254, 325, 32541].
The SIC codes for Intract Pharma are [28, 283].